Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial.

التفاصيل البيبلوغرافية
العنوان: Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial.
المؤلفون: Fujiki, Shinya, Iijima, Kenichi, Nakagawa, Yoshihisa, Takahashi, Kazuyoshi, Okabe, Masaaki, Kusano, Kengo, Owada, Shingen, Kondo, Yusuke, Tsujita, Kenichi, Shimizu, Wataru, Tomita, Hirofumi, Watanabe, Masaya, Shoda, Morio, Watanabe, Masafumi, Tokano, Takashi, Murohara, Toyoaki, Kaneshiro, Takashi, Kato, Takeshi, Hayashi, Hidemori, Maemura, Koji, Niwano, Shinichi, Umemoto, Tomio, Yoshida, Hisako, Ota, Keiko, Tanaka, Takahiro, Kitamura, Nobutaka, Node, Koichi, Minamino, Tohru
المصدر: Cardiovasc Diabetol ; ISSN:1475-2840 ; Volume:23 ; Issue:1
بيانات النشر: BioMed Central
سنة النشر: 2024
المجموعة: PubMed Central (PMC)
مصطلحات موضوعية: Empagliflozin, Sodium-glucose cotransporter 2, Type 2 diabetes, Ventricular arrhythmia
الوصف: Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death with type 2 diabetes; however, their effect on arrhythmias is unclear. The purpose of this study was to investigate the effects of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes.
نوع الوثيقة: report
article in journal/newspaper
اللغة: English
العلاقة: https://doi.org/10.1186/s12933-024-02309-9Test; https://pubmed.ncbi.nlm.nih.gov/38943159Test
DOI: 10.1186/s12933-024-02309-9
الإتاحة: https://doi.org/10.1186/s12933-024-02309-9Test
https://pubmed.ncbi.nlm.nih.gov/38943159Test
حقوق: © 2024. The Author(s).
رقم الانضمام: edsbas.39225AB0
قاعدة البيانات: BASE